Medical Diagnostic Test Kit Supply

The contract seeks the supply of commercial off-the-shelf Abbott BinaxNOW COVID-19 Antigen Self Test kits, all of which must have active FDA authorization, a minimum shelf life of 12 months from the date of delivery, and be manufactured as recently as possible to ensure optimal efficacy and reliability. The kits are intended for use in support of medical readiness and health surveillance operations, with all deliveries required to meet strict quality and expiration standards. The sourcing is structured as a subcontract under the Department of Defense’s Medical Supply Chain, specifically managed by the MD SURG FSF office, and performance is to be executed at FPO, 96677. The opportunity was posted on July 16, 2026, with a response deadline of July 22, 2026, and falls under the NAICS code 325414 for in vitro diagnostic substance manufacturing. The procurement is not subject to any set-aside provisions, and the requirement is open to qualified suppliers capable of meeting the specified technical and logistical conditions. All bids must demonstrate compliance with the FDA authorization status, shelf-life requirements, and manufacturing recency to be considered. The contract does not include a designated point of contact, and interested parties must proceed through the official DIBBS platform at the provided link to submit proposals.